We are live on
!
Find out more
GLRA
Gerald L. Ray & Associates Portfolio holdings
AUM
$802M
1-Year Est. Return
21.01%
This Fund
S&P 500
This Quarter
Est. Return
+1.97%
1 Year Est. Return
+21.01%
3 Year Est. Return
+38.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$665M
AUM Growth
+$14.2M
(+2.2%)
Cap. Flow
+$8.27M
Cap. Flow
% of AUM
1.24%
Top 10 Holdings %
Top 10 Hldgs %
29.06%
Holding
320
New
17
Increased
94
Reduced
63
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ford
F
|
+$1M |
| 2 |
WPZ
Williams Partners L.P.
WPZ
|
+$889K |
| 3 |
RTX Corp
RTX
|
+$824K |
| 4 |
EOG Resources
EOG
|
+$815K |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$623K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$888K |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$774K |
| 3 |
WPZ
WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT
WPZ
|
+$754K |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$532K |
| 5 |
HP
HPQ
|
+$522K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.19% |
| 2 | Industrials | 14.52% |
| 3 | Consumer Staples | 10.31% |
| 4 | Energy | 8.33% |
| 5 | Technology | 8.27% |
Similar funds
KRC
GS
PAAMCP
B
JPCCM
NBC
NTC
SD
Gerald L. Ray & Associates's Q1 2015 Portfolio in Review
As of Q1 2015, Gerald L. Ray & Associates held 320 positions worth $665M, up 2.2% from $650M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Gerald L. Ray & Associates's Q1 2015 filing shows 17 new, 94 increased, 63 reduced and 8 closed positions. Its largest new stake was Williams Partners L.P.: 18,217 shares worth $897K. The largest sale was PHARMACYCLICS INC, an estimated $888K.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Industrials and Consumer Staples.
- Gerald L. Ray & Associates's largest Q1 2015 buy was Williams Partners L.P.: 18,217 shares worth $897K.
- Gerald L. Ray & Associates added most to Ford in Q1 2015, an estimated $1M increase.
- Gerald L. Ray & Associates's biggest Q1 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $532K.
- Gerald L. Ray & Associates fully exited PHARMACYCLICS INC in Q1 2015, selling an estimated $888K.
- Gerald L. Ray & Associates's ten largest holdings make up 29% of its $665M portfolio in Q1 2015.
- Gerald L. Ray & Associates opened 17 new positions and closed 8 in Q1 2015.
- Gerald L. Ray & Associates's portfolio value rose 2.2% quarter-over-quarter to $665M.
Based on Gerald L. Ray & Associates's 13F filing for Q1 2015, filed 6 May 2015.